Independent. Not owned by or funded by any pharmaceutical manufacturer.
Evidence-sourced · medically-reviewed where indicated
GLP-1 HealthcareThe independent GLP-1 resource
Site index

Sitemap

All 113 pages on this site, grouped by section. Looking for the machine-readable version? It’s at /sitemap.xml.

Start here

The main entry point to the site.

  • HomeWhat GLP-1 Healthcare is, what we cover, and why you can check our work./

GLP-1 guides

Plain-language explanations of the medication class itself.

  • GLP-1 medications: the complete guideThe hub for every guide in this section, plus what's coming next./glp-1
  • How GLP-1 works: the hormone, and the drugs that copy itThe hormone lasts minutes, the drugs copying it last days, and the label says what the difference is made of — plus the four mechanisms, and why they cause the side effects too./glp-1/how-it-works
  • GLP-1 statistics, sourced and datedUsage and prevalence, clinical trial efficacy by drug, FDA-label side-effect rates, market spending, persistence, and insurance coverage — every figure dated and cited./glp-1/statistics
  • GLP-1 weight loss calculatorYour BMI, whether you meet the FDA label thresholds, and what proportion of trial participants reached each weight-loss threshold at your starting weight — with the placebo arm beside every figure./glp-1/weight-loss-calculator
  • GLP-1 drug interactionsWhat the approved labels say about taking something else alongside a GLP-1, and the longer list they say nothing about — including the contraception warning that applies to tirzepatide and orforglipron but not semaglutide./glp-1/interactions
  • GLP-1 medications if you take immunosuppressantsWhat the pooled evidence shows in solid organ transplant recipients — including tacrolimus trough levels — and why the absence of randomised trials matters./glp-1/immunosuppression
  • GLP-1 medications and autoimmune diseaseWhether these drugs weaken immunity, reduce inflammation, or change an autoimmune disease — three questions with three different answers, and what has and has not been studied in each condition./glp-1/autoimmune-disease
  • Where to actually buy a GLP-1The four decisions every route runs through, in the order they happen — starting with the prescription, which rules out most of what gets advertised to people searching this./glp-1/where-to-buy
  • How long a GLP-1 takes to work, lasts, and keepsThree different “how long” questions answered from the labels: when blood levels plateau, how long the drug stays in you, and the five different out-of-fridge allowances./glp-1/how-long
  • GLP-1 lawsuitsWhat the eight products' own FDA labels say about the injuries being litigated — and the one claim no label mentions at all./glp-1/lawsuits
  • What we cover, and what we don'tEvery subject we mapped, which have a page behind them, and the stated reason for each one that doesn't./glp-1/coverage
  • Compounded semaglutideNot a grade or a generic but a legal category — who made the preparation, under which law, and what nobody has reviewed./glp-1/compounded-semaglutide
  • GLP-1 glossaryA searchable glossary of GLP-1 and related medication terms — drug names, dosing, side effects, compounding, insurance, and clinical-trial terminology./glp-1/glossary
  • Muscle preservation during GLP-1 treatmentHow to interpret lean-mass findings and protect strength with an evidence-aware learning path./glp-1/muscle-preservation
  • GLP-1 reconstitution and product identificationWhy preparation is product-specific, what to verify, and how to avoid concentration and syringe-unit errors./glp-1/reconstitution
  • Can you raise your GLP-1 naturally?Your body makes GLP-1 and food does stimulate it — but it lasts minutes, while the medications last days. Why that difference in duration, not quantity, decides the question./glp-1/natural-alternatives
  • GLP-1 supplementsWhat the label is actually claiming, the ingredients that recur, and the duration problem that survives even a generous reading./glp-1/natural-alternatives/supplements
  • Every approved GLP-1 medicationSix approved products built from four molecules — molecule, approved use, dosage form and published price, with a page for each./glp-1/drugs
  • WegovyWegovy (semaglutide): approved use, dosage form, published self-pay price, and where it sits against the rest of the class./glp-1/drugs/wegovy
  • ZepboundZepbound (tirzepatide): approved use, dosage form, published self-pay price, and where it sits against the rest of the class./glp-1/drugs/zepbound
  • FoundayoFoundayo (orforglipron): approved use, dosage form, published self-pay price, and where it sits against the rest of the class./glp-1/drugs/foundayo
  • OzempicOzempic (semaglutide): approved use, dosage form, published self-pay price, and where it sits against the rest of the class./glp-1/drugs/ozempic
  • MounjaroMounjaro (tirzepatide): approved use, dosage form, published self-pay price, and where it sits against the rest of the class./glp-1/drugs/mounjaro
  • TrulicityTrulicity (dulaglutide): a once-weekly GLP-1 for type 2 diabetes, with a cardiovascular risk-reduction indication — and no approved use for weight management./glp-1/drugs/trulicity
  • VictozaVictoza (liraglutide): once-daily, for type 2 diabetes. Same molecule as Saxenda, different dose and different approved use./glp-1/drugs/victoza
  • SaxendaSaxenda (liraglutide): once-daily at 3 mg, the older agonist approved for chronic weight management rather than diabetes./glp-1/drugs/saxenda
  • ByettaByetta (exenatide): injected twice daily before meals — the oldest dosing schedule in the class./glp-1/drugs/byetta
  • RybelsusRybelsus (semaglutide): approved use, dosage form, published self-pay price, and where it sits against the rest of the class./glp-1/drugs/rybelsus
  • GLP-1 comparisonsThe comparisons people actually search for — class versus molecule versus brand, and pill versus injection./glp-1/comparisons
  • GLP-1 vs semaglutide vs OzempicA class, a molecule, and a brand name — three levels of one thing, and why the comparison keeps being framed as three products./glp-1/comparisons/glp1-vs-semaglutide
  • Is it a GLP-1?Symlin is not. Trulicity and Victoza are. There is no such thing as a GLP-1 inhibitor — each answer checked against the drug's own FDA label./glp-1/comparisons/is-it-a-glp-1
  • GLP-1 vs GLP-2 vs GLP-3Two of those are hormones from the same gene and the same gut cells, doing different jobs. There is no GLP-3 — the term is shorthand for investigational multi-agonists./glp-1/comparisons/glp1-vs-glp2-vs-glp3
  • Semaglutide vs tirzepatideThe one comparison in this category with a real head-to-head trial behind it — and the cardiovascular question that has no comparison at all./glp-1/comparisons/semaglutide-vs-tirzepatide
  • Liraglutide vs semaglutideCompared directly twice, at different doses. Semaglutide won decisively on weight — and the two trials disagree about which is better tolerated./glp-1/comparisons/liraglutide-vs-semaglutide
  • GLP-1 pill vs injectionThe injections led on trial results; the cheapest published self-pay price belongs to a tablet. What each format trades./glp-1/comparisons/pill-vs-injection
  • GLP-1 research compoundsA safety-first guide to investigational evidence and why research-use products are not medicines./glp-1/research-compounds

Side effects & safety

What's common, what settles on its own, and what needs urgent medical attention.

  • GLP-1 side effects: what's common and what's seriousCommon digestive effects, red-flag symptoms, the boxed warning, and who should not take these./glp-1/side-effects
  • Is GLP-1 safe?“Safe” is a comparison over a time horizon, not a yes or no — what the trials established, what is known to go wrong, and how far past the evidence long-term use runs./glp-1/side-effects/is-glp-1-safe
  • GLP-1 constipationWhy slowed digestion causes it, what actually helps, and the warning signs./glp-1/side-effects/constipation
  • GLP-1 medications and sleep apnoeaOne GLP-1 medication carries an FDA approval for obstructive sleep apnoea in adults with obesity — what an approval means, and why it is not a reason to stop CPAP./glp-1/side-effects/sleep-apnea
  • GLP-1 medications and alcoholMany people report wanting to drink less, and it has now been tested in a randomised trial — but it is not an approved use, and whether you can safely drink is a separate question./glp-1/side-effects/alcohol
  • “Ozempic face”: what it actually isFacial hollowing is subcutaneous facial fat lost along with the rest, at a speed the skin has not kept up with — not the drug acting on your face./glp-1/side-effects/glp1-face
  • Does semaglutide make you tired?Labelled at 11% against 5% on placebo — real, the least common labelled effect, and mostly downstream of eating far less./glp-1/side-effects/fatigue
  • Does GLP-1 cause hair loss?Why shedding is usually telogen effluvium from rapid weight loss — and usually temporary./glp-1/side-effects/hair-loss

Cost & coverage

What these medications actually cost, and how to pay less for them.

  • GLP-1 cost and insurance coverageFind your cost pathway by medication and insurance type, plus savings-programme eligibility and how to appeal a denial./glp-1/cost
  • The Medicare GLP-1 Bridge programmeA flat $50 a month for eligible Part D enrollees — which formulations qualify, the eligibility conditions, and the caveats that decide what it is worth./glp-1/cost/medicare-bridge-program
  • The cheapest way to get a GLP-1Every route to a GLP-1 priced side by side — insurance, Medicare, manufacturer direct, and online providers — with membership fees added in and every figure dated./glp-1/cost/cheapest
  • GLP-1 price trackerA dated record of published GLP-1 prices — what has moved, what sellers have announced but not yet done, and the data as a downloadable series./glp-1/cost/price-tracker
  • Buying a GLP-1 from a Canadian or overseas pharmacyThe FDA's conditions for tolerating personal importation are published, and GLP-1s fail two of them — including the one that rules out any product promoted to people living in the US./glp-1/cost/international
  • The cheapest semaglutide, by formThe only GLP-1 molecule you can swallow, and the tablet is the cheapest published route to any approved product in the class — with every provider that names semaglutide priced beside it./glp-1/cost/semaglutide
  • What tirzepatide costs, and why there is no cheap tabletNo approved oral form exists, so the cheap route available for semaglutide is absent here — every provider that names tirzepatide, priced, plus the litigation affecting the compounded end./glp-1/cost/tirzepatide

Dosing & administration

How these medications are started, escalated, and injected.

  • GLP-1 dosing and titration explainedWhy doses start low and climb slowly, handling missed doses, and what to ask your prescriber./glp-1/dosing
  • GLP-1 titration trackerWhich rung of the escalation you are on, whether the label counts that dose as treatment at all, how long until the dose the published results were measured at, and your product's own missed-dose rule./glp-1/dosing/titration-tracker
  • GLP-1 injection sites and rotationThe three approved sites, how to rotate, what to avoid, and safe sharps disposal./glp-1/dosing/injection-sites

Diet & nutrition

What to eat, and why — grounded in body-composition trial data, not a fad diet.

Delivery formats

Which formats actually deliver a GLP-1 receptor agonist, and which borrow the name.

  • GLP-1 delivery formats: what's real and what just uses the nameInjections and oral tablets are approved GLP-1 medications; patches, gummies, and drops contain no GLP-1 drug. How to tell them apart./glp-1/formats
  • Is there a GLP-1 pill?Three FDA-approved oral GLP-1 medications exist. What each treats, how the two chemical kinds differ in daily use, and how they compare to the injections on trial results./glp-1/formats/glp-1-pill
  • The GLP-1 shotA weekly injection into fat just under the skin — the approved injectables, why the device changes the price and the coverage, and how shots compare to tablets./glp-1/formats/glp-1-shot
  • Do GLP-1 patches work?No approved transdermal GLP-1 exists, and the chemistry explains why: semaglutide is about eight times heavier than the largest molecule that passively crosses skin./glp-1/formats/glp-1-patch
  • GLP-1 gummies: what they containDietary supplements containing no semaglutide or tirzepatide, sold on a claim to support your body's own GLP-1./glp-1/formats/glp-1-gummies
  • GLP-1 dropsMostly supplements — but some liquids are unapproved semaglutide labelled for research use, which the FDA has acted against./glp-1/formats/glp-1-drops

Microdosing

What's actually known about low-dose GLP-1 use, and what isn't.

Finding care

A data-rich, unranked comparison of telehealth providers prescribing GLP-1 medications.

  • GLP-1 telehealth provider directoryProviders compared by access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures — not ranked./glp-1/find-a-provider
  • Getting a GLP-1 through Walgreens or CVSBoth national chains now prescribe GLP-1s themselves, and neither charges a membership — $49 a visit at Walgreens, $29 at CVS MinuteClinic, with what each publishes about price, insurance and who it turns away./glp-1/find-a-provider/retail-pharmacy
  • What changedA dated, sourced log of price changes, terms changes, litigation and regulatory action affecting the providers this site reports on — including three of our own mistakes./glp-1/find-a-provider/changes
  • How a provider gets listedThe full standard a provider must meet to appear in the directory, which parts we verify, and the four we publish without verifying — with what verifying each would take./glp-1/find-a-provider/standards
  • How to choose an online GLP-1 providerThe four questions that eliminate providers before quality is in question, and which of them the published record can answer — including state coverage, which nine of the fifteen do not publish at all./glp-1/find-a-provider/online-providers
  • Getting a GLP-1 prescription onlineThe five stages end to end, the two that genuinely differ between services, and what a decline actually means./glp-1/find-a-provider/getting-a-prescription
  • Find your GLP-1 provider matchA free 4-question tool that shortlists directory providers by medication, payment, and support preferences — not a ranking./glp-1/find-a-provider/match
  • Amazon One MedicalAmazon One Medical: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Amazon One Medical's own published terms./glp-1/find-a-provider/amazon-one-medical
  • CalibrateCalibrate: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Calibrate's own published terms./glp-1/find-a-provider/calibrate
  • Hims & HersHims & Hers: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Hims & Hers's own published terms./glp-1/find-a-provider/hims-hers
  • PlushCarePlushCare: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from PlushCare's own published terms./glp-1/find-a-provider/plushcare
  • Ro (Body)Ro (Body): access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Ro (Body)'s own published terms./glp-1/find-a-provider/ro
  • WeightWatchers ClinicWeightWatchers Clinic: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from WeightWatchers Clinic's own published terms./glp-1/find-a-provider/weightwatchers-clinic
  • AlloyAlloy: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Alloy's own published terms./glp-1/find-a-provider/alloy
  • FoundFound: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Found's own published terms./glp-1/find-a-provider/found
  • Noom MedNoom Med: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Noom Med's own published terms./glp-1/find-a-provider/noom-med
  • SesameSesame: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Sesame's own published terms./glp-1/find-a-provider/sesame
  • DelilahDelilah: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Delilah's own published terms./glp-1/find-a-provider/delilah
  • Fella HealthFella Health: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Fella Health's own published terms./glp-1/find-a-provider/fella-health
  • Henry MedsHenry Meds: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Henry Meds's own published terms./glp-1/find-a-provider/henry-meds
  • Mochi HealthMochi Health: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Mochi Health's own published terms./glp-1/find-a-provider/mochi-health
  • Willow HealthWillow Health: access model, medications offered, prescriber type, insurance, pricing, and compounding disclosures, sourced from Willow Health's own published terms./glp-1/find-a-provider/willow-health

Our standards

How we work, where our information comes from, and how we're funded — published so you can check us.

  • Editorial PolicyOur evidence hierarchy, sourcing and review process, freshness rules, and corrections policy./editorial-policy
  • UpdatesThings that changed, on the date they changed. If the date does not matter, it belongs on a reference page instead./updates
  • The September 2026 provider sweepTwo prices moved, our own cost model was wrong by $29 a month, and two figures we publish could not be re-confirmed./updates/provider-sweep-2026-09
  • The August 2026 provider sweepWhat changed across all fifteen provider records on 11 August 2026, the two figures we had wrong, and the five providers whose prices are no longer readable./updates/provider-sweep-2026-08
  • The proposal that would end bulk-compounded GLP-1sComments closed 30 July 2026 on an FDA proposal to leave semaglutide, tirzepatide and liraglutide off the 503B bulks list. Decision pending./updates/fda-503b-bulks-list-glp-1
  • CorrectionsEvery correction to published content, with the old claim stated in full. Currently empty, and it says so./corrections
  • Our SourcesThe named authorities we draw from, grouped into five tiers of evidence./our-sources
  • About GLP-1 HealthcareWho we are, why we exist, and where we are today./about
  • How We're FundedThe funding we refuse, how we may earn revenue, and the wall between the two./about/how-were-funded

The terms you're reading under, what we do with data, and the limits of what this site can tell you.

  • Medical DisclaimerWhy this site is education and not medical advice, and what that means before you act on it./medical-disclaimer
  • Privacy PolicyWhat we collect — currently no cookies, no analytics, no accounts, no forms./privacy
  • Terms of UsePermitted use, intellectual property, disclaimers, and limitation of liability./terms
  • Accessibility StatementThe standard we target, what's built in, and the limitations we know about./accessibility
  • Cookie PolicyWe set no cookies of any kind — every standard category, and why there is no cookie banner./cookie-policy
  • California Privacy NoticeCCPA/CPRA rights, every statutory category of personal information assessed, and why there is no sale or share to opt out of./california-privacy
  • Your Privacy ChoicesWe do not sell or share personal information or run behavioural advertising — so there is no opt-out to submit./your-privacy-choices
  • International Privacy Notice (UK & EEA)UK and EU GDPR rights, our lawful basis for the only data we process, and how transfers are handled./international-privacy
  • HIPAA and Your Health InformationWe are not a HIPAA covered entity or business associate — what that means here, and where HIPAA does apply to you./hipaa-notice
  • Advertising and Affiliate DisclosureNo advertising, no sponsorship, no affiliate commission — every commercial arrangement stated, under the FTC Endorsement Guides./advertising-disclosure
  • Copyright and DMCA PolicyWhat we own, what we quote and why that is lawful, and how to submit a takedown or counter-notice./copyright
  • Security and Vulnerability DisclosureHow to report a vulnerability, what is in and out of scope, and our safe-harbour commitment to researchers./security
  • Legal and Trust CentreEvery legal, privacy, and disclosure document on this site, in one index./legal
  • Contact UsReport an error, ask a privacy or legal question, or enquire about clinical review./contact

Reference

Supporting pages for press, partners, and navigation.

  • Brand GuidelinesOur identity system: logo, colour, typography, voice, and usage rules./brand
  • SitemapEvery page on this site, organised by section./sitemap

More guides are on the way

We publish a page only once it meets our evidence standard, so this list grows steadily rather than all at once. See what’s in progress on the GLP-1 guides hub, or read how we decide what to publish in our Editorial Policy.